Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by FarmerBetty on May 17, 2022 5:34pm

MD&A

Noticed with spending that they allocated to one time fee's $970,135 related to a potential listing on a major North American stock exchange (subject to meeting applicable quantitative and qualitative listing standards of such stock exchange). Seems  rich to me but i'm not sure. Was pointless to be talking over the past years for a million dollar ticket which they couldn't have afforded, but why are they using the words a "potential listing"?
Comment by azzymaa on May 17, 2022 6:35pm
Penny Stock - Not Legit Nasday Listed - Legit
Comment by FarmerBetty on May 17, 2022 7:08pm
Yes, Acumen who Promis mentions in there Corporate update went from 10 months ago $21 on the Nasdaq to $3.65 today. Does wonders!!
Comment by bball67 on May 18, 2022 7:33am
Promis needs to drop the comparison to Acumen which was originally to point out the disparity in market caps. The listing fee of $970k is very high. NASDAQ  listing fees have apparently gone up huge. They are saying potential listing because they need to meet the criteria and the lawyers want to protect the Company.
Comment by G1945V on May 18, 2022 8:20am
They should move quickly with the Reverse Stock Split Consolidation and expedite a NASDAQ listing without any further deals. The fee of $970K is a small price to pay to get PMN on the US Stock Exchange and be done with it. jmo G1945V
Comment by FarmerBetty on May 18, 2022 10:54am
Never did need the Nasdaq listing, what they fail to provide over the years is material news. If they did the stock would perform nicely on the tsx!! 
Comment by G1945V on May 18, 2022 11:51am
What material news have they not provided in your opinion that would or would have boosted the share price? G1945V
Comment by M101 on May 18, 2022 1:49pm
Even Gene and Elliot knew this in 2015, but they didn't have the cash or connections to take it private and avoid the need to manufacture news for the 5-10 years prior to clinical trials.  The old men and the sea.
Comment by goldtech on May 18, 2022 8:39pm
Gene and Elliott had no plans to take this private and continually did cheap financing to steal money for themselves and get ridiculously cheap option shares. This pathetic board has no market savy and should have been replaced years ago. One thing they counted on was once they are voted in shareholders rarely dissent to change and are sheep. Live with what you voted for!!!!!!
Comment by Speyeder999 on May 18, 2022 9:42pm
And yet, independent (ahem) advisory proxy firms ISS and Glass Lewis fully recommended to have all directors re-elected. Would love to know what criteria they used to base their decision on.......
Comment by M101 on May 18, 2022 11:33pm
Yes, exactly, they had no plans because they couldn't do it without losing control. They kept it public instead and tried to keep control through ever-worse band-aid financings instead of courting major investors, until facing bankruptcy they had no choice.   So for those who missed the Hemmingway reference (since it got no likes): An old fisherman in small boat catches the fish of his ...more  
Comment by FarmerBetty on May 18, 2022 10:58pm
Maybe Elliott was doing the consulting?
Comment by FarmerBetty on May 18, 2022 11:00pm
Meant the Nasdaq or major index listing!!!
Comment by FarmerBetty on May 18, 2022 11:17pm
Meant the cost??
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities